Longevity Biomedical, Inc. and FutureTech II Acquisition Corp. Announce Business Combination to Create Nasdaq-Listed Biopharmaceutical Company Focused on Advancing New Technologies to Promote Human Health and Longevity
September 20, 2024 14:55 ET
|
FutureTech II Acquisition Corp.
-Longevity Biomedical, Inc. is focused on developing and acquiring new technologies spanning therapeutics, health monitoring and digital health solutions to become a leading provider of...
Samsung Bioepis and Biogen Receive Positive CHMP Opinion for Aflibercept Biosimilar, OPUVIZ™
September 20, 2024 08:00 ET
|
Samsung Bioepis
OPUVIZ™, a biosimilar referencing Eylea1 (aflibercept), is Samsung Bioepis and Biogen’s second ophthalmology biosimilar to be recommended for marketing authorization by the European Medicines Agency ...
U.S. Veterinary Eye Care Market Analysis and Forecast, 2019-2029: A $102.8 Million Opportunity, Dominated by Reichert, Innovacyn, Boehringer Ingelheim Animal Health USA
September 20, 2024 07:11 ET
|
Research and Markets
Dublin, Sept. 20, 2024 (GLOBE NEWSWIRE) -- The "United States Veterinary Eye Care Market, By Region, Competition, Forecast & Opportunities, 2019-2029F" report has been added to ...
Apellis Receives Negative CHMP Opinion for Pegcetacoplan for Geographic Atrophy (GA) in the EU Following Re-Examination
September 20, 2024 05:00 ET
|
Apellis Pharmaceuticals, Inc.
WALTHAM, Mass., Sept. 20, 2024 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European...
Oculis and EURETINA Announce the Winner of the Inaugural Ramin Tadayoni Award
September 19, 2024 13:00 ET
|
Oculis Holding AG
ZUG, Switzerland, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS) (“Oculis”), a global biopharmaceutical company purposefully driven to save sight and improve eye care, in...
Rejuveron Life Sciences AG Rebrands as Centenara Labs AG and Provides Latest Clinical Updates
September 19, 2024 10:00 ET
|
Centenara Labs AG
Shareholders approve name change and rebranding to Centenara Labs AG (“Centenara”)Rebrand positions business for strategic initiatives designed to support development of therapies for regenerative...
Eyconis, Inc. Announces Appointment of Dr. Mark J. Bachleda as Chief Executive Officer and Member of the Board of Directors
September 19, 2024 08:00 ET
|
Eyconis, Inc.
REDWOOD CITY, Calif., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Eyconis, Inc., a biopharmaceutical company focused on developing novel, best-in-class therapeutics for eye diseases, today announced that...
4DMT Highlights Robust and Durable Clinical Activity for 4D-150 and Design of 4FRONT Phase 3 Program at 4D-150 Wet AMD Development Day
September 18, 2024 16:05 ET
|
4D Molecular Therapeutics, Inc.
4D-150 demonstrated robust and durable clinical activity across all wet age-related macular degeneration (wet AMD) patient populations based on longest available follow-up data In broad population...
Corza Medical Named to the 2024 MedTech Big 100 List
September 18, 2024 08:55 ET
|
Corza Medical Inc.
Corza Medical, a leading global medical technology company committed to remarkable service, trusted performance, and outstanding value named to BIG100!
Nicox Announces Approval of ZERVIATE in China
September 18, 2024 01:30 ET
|
NICOX SA
Press Release Nicox Announces Approval of ZERVIATE in China Nicox’s partner, Ocumension Therapeutics, has received approval for ZERVIATE® for ocular itching in China ZERVIATE® launch in China will...